HR+/HER2- High-risk Breast Cancer Therapy
Improving Outcomes in Patients With High-risk Breast Cancer: Outcomes and Analysis From an Educational Program on HR+/HER2- Early and Metastatic Breast Cancer

Released: December 11, 2024

Expiration: December 10, 2025

Yara Abdou
Yara Abdou, MD
Stephanie L. Graff
Stephanie L. Graff, MD, FACP, FASCO
Tanya Gupta
Tanya Gupta, MD
Jane Lowe Meisel
Jane Lowe Meisel, MD, FASCO
Michelle Melisko
Michelle Melisko, MD
Laura Spring
Laura Spring, MD

Activity

Progress
1
Course Completed